Antidepressants and antianxiety medication Flashcards

(179 cards)

1
Q

Most sedating SSRI

A

Paroxetine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Reason for paroxetine’s sedating effect

A

High H1 affinity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

SSRI with the highest rate of discontinuation symptoms

A

Paroxetine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

SSRIs with the highest rates of drug interactions

A

Fluoxetine
Fluvoxamine
Paroxetine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

SSRI which causes the most short term anxiety and agitation

A

Fluoxetine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

SSRI which causes the most short term weight loss

A

Fluoxetine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

SSRI which has the least drug interactions

A

Citalopram

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

SSRI which is most often used with elderly patients due to its lower risk of interactions

A

Citalopram

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

SSRI which has the most evidence for safe use post-MI

A

Sertraline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

SSRI which is most often used for children and adolescents

A

Fluoxetine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Most common side effect of SSRIs

A

GI side effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

SSRI which causes the most GI upset

A

Fluvoxamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

SSRIs which cause the least sexual dysfunction

A

Vortioxetine

Fluvoxamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

SSRI which is the most anticholinergic

A

Paroxetine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Medication which should be co-prescribed if a patient is taking an SSRI and NSAID

A

Protein pump inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Drugs where SSRIs should be avoided where possible

A

NSAIDs
Warfarin
Aspirin
Triptans

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

SSRI which does not need to be gradually reduced when stopping

A

Fluoxetine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

SSRI discontinuation symptoms

A
Restlessness
Insomnia, vivid dreams
Unsteadiness/dizziness
Sweating
GI symptoms - pain, cramps, diarrhoea, vomiting
Paraesthesia, shock-like symptoms
Flu-like symptoms
Crying spells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Half life of citalopram

A

33 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Half life of escitalopram

A

30 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Half life of fluoxetine in early use

A

1-3 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Half life of fluoxetine with prolonged use

A

4-6 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Half life of fluvoxamine

A

17-22 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Half life of paroxetine

A

22 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Half life of sertraline
26 hours
26
Mechanism of action of MAOIs
Block the monoamine oxidase enzyme, which breaks down different neurotransmitters
27
Where MAO A is found
Placenta, gut, liver
28
Where MAO B is found
Brain, liver, platelets
29
Neurotransmitters MAO A breaks down
Serotonin, noradrenaline, dopamine, tyramine
30
Neurotransmitters MAO B breaks down
Phenylethylamine, methylhistamine, tryptamine, dopamine, tyramine
31
Types of MAOIs
Reversible or irreversible, selective for MOA A or MOA B, or non-selective
32
Irreversible and selective inhibitors of MAO B
Selegiline (no longer selective at high doses)
33
Reversible and selective inhibitor of MAO A
Meclobemide
34
Most common adverse effects
Dry mouth, nausea, diarrhoea, constipation, insomnia, dizziness/light-headedness
35
Cause of MAOI cheese reaction
Tyramine is a monoamine found in different foods which displaces noradrenaline from neurons, causing hypertension. When MAO doesn't break down tyramine it can build up and cause a hypertensive reaction
36
Foods to avoid due to risk of cheese reaction
``` Cheese (except cream cheese and cottage cheese) Broad beans Alcohol Banana peels Bean curd Sauerkraut Yeast extracts (e.g. marmite) ```
37
First generation TCAs (tertiary amines)
``` Amitriptyline Lofepramine Imipramine Dosulepin Doxepin Clomipramine ```
38
Second generation TCAs (secondary amines)
Nortriptyline Desipramine Amoxapine
39
Most dangerous TCAs in overdose
Amitriptyline | Dosulepin - possibly the most dangerous
40
Common side effects of TCAs
``` Drowsiness Dry mouth Blurred vision Constipation Urinary retention ```
41
Features of overdose of TCAs
``` Sedation/coma Seizures Hypertension (early) then hypotension Tachycardia Broad complex dysrhythmias Increased anticholinergic side effects ```
42
ECG features of TCA overdose
Increased QRS - >100ms in lead II Terminal R wave >3mm in aVR Sinus tachycardia
43
Specific treatments for overdose of TCAs
IV sodium bicarbonate Hyperventilation IV lidocaine Avoid 1a (procainamide) and 1c (flecainide) antiarrhythmics, beta-blockers and amiodarone
44
Drug interactions of TCAs
Cytochrome p450 inhibitors can lead to toxicity as TCAs are highly metabolised by cytochrome p450 Cytochrome p450 inducers can lead to treatment failure MAOIs - contraindicated with some TCAs due to serotonin syndrome like reactions QTc prolonging drugs
45
Mechanism of action of TCAs
Block the serotonin transporter and the noradrenaline transporter which leads to elevated synaptic concentrations of serotonin and noradrenaline Weak affinity for the dopamine transporter Antagonists of multiple receptors including 5-HT2 Inhibit sodium channels leading to their cardiotoxicity in overdose
46
Interaction of TCAs with warfarin
TCAs increase warfarin levels - high risk of bleeding
47
Interaction of TCAs with clonidine
TCAs decrease clonidine levels - risk of hypertension
48
Interaction of TCAs with MAOIs
Increase serotonin levels via synergistic serotonergic enhancement - increased risk serotonin syndrome like reaction Decrease tyramine entry - reduced risk cheese reaction
49
Interaction between TCAs and levodopa
Reduces absorption of levodopa and so lowers efficacy
50
Active metabolite of amitriptyline
Nortriptyline
51
Active metabolite of clomiprimine
Desmethyl-clomipramine
52
Active metabolite of dosulepin
Desmethyldosulepin
53
Active metabolite of doxepin
Desmethyldoxepin
54
Active metabolite of imipramine
Desipramine
55
Active metabolite of lofepramine
Desipramine
56
Active metabolite of fluoxetine
Norfluoxetine
57
Active metabolite of mirtazapine
Demethyl-mirtazapine
58
Active metabolite of trazadone and nefazodone
mCPP
59
Active metabolite of venlafaxine
O-desmethyl-venlafaxine
60
Start dose of citalopram for depression
10-20mg/day
61
Maximum citalopram dose for depression
40mg/day
62
Start dose of escitalopram for depression
5-10mg/day
63
Maximum escitalopram dose for depression
20mg/day
64
Start dose of sertraline for depression
50mg/day
65
Maximum sertraline dose for depression
200mg/day
66
Start dose of fluoxetine for depression
20mg/day
67
Maximum fluoxetine dose for depression
60mg/day
68
Start dose of paroxetine for depression
20mg/day
69
Maximum dose of paroxetine for depression
50mg/day
70
Start dose of vortioxetine for depression
5-10mg/day
71
Maximum vortioxetine dose for depression
20mg/day
72
Start dose of venlafaxine for depression
75mg/day in divided doses
73
Maximum venlafaxine dose for depression
375mg/day
74
Start dose of mirtazapine for depression
15mg/day
75
Maximum mirtazapine dose for depression
45mg/day
76
Start dose of moclobemide for depression
300mg/day in divided doses
77
Usual dose of moclobemide for depression
Up to 600mg/day
78
TCA discontinuation symptoms
Flu-like symptoms Insomnia Excessive dreaming
79
MAOI discontinuation symptoms
Agitation Ataxia and movement disorders Insomnia Vivid dreams
80
Discontinuation symptoms associated with agomelatine
Nil
81
Minimum effective dose of citalopram
20mg/day
82
Minimum effective dose of fluoxetine
20mg/day
83
Minimum effective dose of fluvoxamine
50mg/day
84
Minimum effective dose of paroxetine
20mg/day
85
Minimum effective dose of sertraline
50mg/day
86
Minimum effective dose of mirtazapine
30mg/day
87
Minimum effective dose of venlafaxine
75mg/day
88
Minimum effective dose of duloxetine
40-60mg/day
89
Minimum effective dose of agomelatine
25mg/day
90
Minimum effective dose of moclobemide
300mg/day
91
Minimum effective dose of trazadone
150mg/day
92
Starting dose of fluvoxamine
50-100mg/day
93
Maximum dose of fluvoxamine
300mg/day
94
Starting dose of agomelatine
25mg/day
95
Maximum dose of agomelatine
50mg/day
96
Starting dose of trazodone
150mg/day in divided doses
97
Maximum dose of trazodone
300mg/day generally | 600mg/day in hospital inpatients
98
Non selective MAO A and MAO B inhibitors (all irreversible)
Hydrazine Phenelzine Tranylcypromine Hydracarbazine
99
Antidepressant that can be given sublingually
Fluoxetine liquid
100
Antidepressants that can be given buccally
Selegiline | Amitriptyline
101
Antidepressants that can be given IV
``` Citalopram Escitalopram Mirtazapine Amitriptyline Clomipramine Ketamine ```
102
IM antipsychotic which has been shown to have antidepressant effects
Flupentixol
103
Antidepressant that can be given transdermally
Selegiline
104
Antidepressants that exist as suppositaries
Amitriptyline Clomipramine Imipramine Trazodone
105
TCA side effects
``` Antimuscarinic - dry mouth, urinary retention Weight gain Sedation Sexual dysfunction Cognitive impairment Arrhythmias Black hairy tongue Tremor Altered LFTs Paralytic ileus NMS ```
106
Active metabolite of sertraline
Desmethylsertraline
107
Dose at which antianxiety effects of trazadone appear compared to antidepressant effects
Antianxiety effects occur at lower doses
108
Number of times a day buspirone is given
3
109
Active metabolite of buspirone
1-pyrimidinylpiperazine
110
Impact of bupropion on seizures
Dose related risk of seizures | Worse with instant release preparations
111
Treatment combinations with good evidence for treatment resistant depression
SSRI or venlafaxine PLUS mirtazapine or mianserin
112
Treatment combination for treatment resistant depression known as 'California rocket fuel'
SNRI and mirtazapine
113
Enantiomers present in citalopram
R and S
114
Enantiomer present in escitalopram
Pure S enantiomer
115
Benefit to using escitalopram rather than citalopram
R enantiomer of citalopram has antihistaminic properties - using escitalopram removes these Citalopram has inconsistent therapeutic action due to the R enantiomer and dose often needs to be increased, but can't due to QTc prolongation - using escitalopram lower doses can often be used and there are no higher dose restrictions to avoid prolonging the QTc
116
Main clinical use for buspirone
Generalised anxiety disorder
117
Hormone given to treat depression
Thyroid hormone
118
TCA which is most preferable with elderly patients
Lofepramine
119
Age group who clear TCAs fastest
Children/adolescents
120
SSRI most selective for serotonin reuptake
Citalopram
121
SSRI with the longest half life
Fluoxetine
122
SSRI active metabolite with the longest half life
Norfluoxetine
123
Antidepressant which shows autoinduction
Paroxetine
124
Mechanism by which TCAs delay their own absorption
Anticholinergic effects
125
Time after stopping SSRI when discontinuation symptoms have usually started
By day 5
126
Discontinuation symptom specific to paroxetine
Suicidal ideation
127
SSRI which causes the most sexual dysfunction
Paroxetine
128
SSRI which causes the most weight gain
Paroxetine
129
First line antidepressant for patients with diabetes
Fluoxetine
130
Drugs to avoid with MAOIs
``` SSRIs SNRIs TCAs - clomipramine and imipramine only Opioids St John's Wort Triptans OTC cold medication - dextromethorphan and chlorpheniramine ```
131
SSRI which can be used to help prevent discontinuation symptoms from venlafaxine and clomipramine
Fluoxetine
132
TCA which shows the highest rates of anticholinergic side effects
Imipramine
133
Time frame to develop antidepressant related hyponatraemia
Usually within the first 30 days
134
Antidepressant which most improves sleep wake cycles in major depression
Agomelatine
135
Alternative name for dosulepin
Dothiepin
136
Most sedating tricyclics
Amitriptyline | Dothiepin
137
Effect on receptors of chronic administration of tricyclics
Causes down-regulation of beta-adrenergic receptors
138
TCA with the most stimulant effect
Desipramine
139
Medication of choice to treat a hypertensive crisis caused by combination of MAOI and tyramine containing food
Alpha adrenergic antagonist e.g. phentolamine, chlorpromazine
140
Antidepressants known for causing weight gain
TCAs | Mirtazapine
141
TCA with the highest antihistaminergic activity
Doxepin
142
SSRI which should be used with the most caution post-MI
Citalopram
143
Effect of bupropion on weight
Moderate sustained weight loss
144
Specific side effect of mianserin that requires regular monitoring
Bone marrow suppression
145
Side effect associated with venlafaxine and bupropion which can be helped by alpha and beta blockers
Sweating
146
Common side effects of MAOIs
``` Postural hypotension Insomnia Peripheral oedema Restlessness Nausea Dizziness Sexual dysfunction Sweating Tremor ```
147
Antidepressant associated with closed angle glaucoma
Paroxetine
148
Principle cause of death in TCA overdose
Cardiac arrhythmia
149
SSRI which is present to high concentrations in breast milk
Fluoxetine
150
Risk factors for antidepressant induced hyponatraemia
Old age Female sex Low BMI Concomitant use of diuretics
151
Antidepressant which can cause dependence
Tranylcypromine
152
Antidepressant which can directly influence gene transcription through nuclear receptors
Tri-iodothyronine
153
Medical condition where the use of MAOIs is contraindicated
Phaeochromocytoma
154
Antidepressant with good efficacy in patients with atypical depression
Phenelzine
155
Antidepressants least likely to precipitate mania in a patient with bipolar disorder
Bupropion | Sertraline
156
Blood test required before starting agomelatine
LFTs
157
Timing of LFTs required in patients taking agomelatine
Baseline | 3, 6, 12, and 24 weeks after starting treatment
158
Antidepressants to consider in patients who have developed antidepressant related hyponatraemia
Nortriptyline Lofepramine MAOIs
159
Likely mechanism of action of SSRI discontinuation syndrome
Temporary deficiency in the brain of one or more essential neurotransmitters associated with mood
160
Antidepressants known as dual action antidepressants
Venlafaxine | Duloxetine
161
Impact of smoking on duloxetine plasma levels
Reduced by up to 50%
162
Mechanism behind the increased risk of bleeding with SSRIs
SSRIs inhibit the serotonin transporter which is responsible for the uptake of serotonin into platelets Depleted platelet serotonin leads to inability to form clots SSRIs increase gastric acid secretion which acts as an irritant to the gastric mucosa, increasing the risk of GI bleeding
163
Antidepressant most associated with waves of withdrawal symptoms
Venlafaxine
164
SSRI with the shortest half life
Fluvoxamine
165
Most serotonergic TCA
Clomipramine
166
Reversible inhibitor of MAO that does not react with tyramine
Moclobemide
167
Antidepressant treatment combination known as California rocket fuel for its effects in treatment resistant depression
Mirtazapine and venlafaxine
168
Antidepressant suggested for patients with hyponatraemia
Agomelatine
169
Mechanism of action of the delayed onset part of antidepressant medication action
Down regulation of HT1A autoreceptors in the post-synaptic neurons
170
Antidepressant classes which cause an increased risk of postpartum haemorrhage
All classes
171
Antidepressant causing the least sexual dysfunction
Agomelatine
172
Time to wait after stopping a MAOI before starting another antidepressant (particularly an SSRI)
2 weeks
173
Least sedating TCAs
Imipramine Lofepramine Nortriptyline
174
Main side effects of buspirone
``` Dizziness Headache Excitement Nausea Dry mouth ```
175
Most notable side effect of ketamine
Dissociation
176
TCA which causes the most weight gain
Doxepin
177
Antidepressant associated with raised cholesterol levels
Mirtazapine
178
Antidepressant discontinued due to risk of severe liver damage
Nefazodone
179
Antidepressants least influenced by pharmacokinetic factors
MAOIs